Efficacy News and Research

RSS
Atlantic examines drug-resistant TB control worldwide

Atlantic examines drug-resistant TB control worldwide

Japan's MHLW approves InSightec's ExAblate MRgFUS system

Japan's MHLW approves InSightec's ExAblate MRgFUS system

ChromoCure publishes results of cervical cancer study using its Chromosomal Scanner Technology

ChromoCure publishes results of cervical cancer study using its Chromosomal Scanner Technology

JDRF and Animas partner to develop an automated system for better control of type 1 diabetes

JDRF and Animas partner to develop an automated system for better control of type 1 diabetes

Cerus' INTERCEPT platelets therapeutically effective even after seven days of storage

Cerus' INTERCEPT platelets therapeutically effective even after seven days of storage

MediSens Wireless to begin its wireless body-monitoring system clinical trials following FDA approval

MediSens Wireless to begin its wireless body-monitoring system clinical trials following FDA approval

CSI receives authorization to begin its pivotal trial of ORBIT II

CSI receives authorization to begin its pivotal trial of ORBIT II

Results from Bionovo's phase 1B clinical trial of Bezielle published

Results from Bionovo's phase 1B clinical trial of Bezielle published

Spectros expands T-Stat product line with new Continuum Cerebral Sensor

Spectros expands T-Stat product line with new Continuum Cerebral Sensor

Synta Pharmaceuticals presents preclinical results of STA-9090 at AACR-IASLC Joint Conference

Synta Pharmaceuticals presents preclinical results of STA-9090 at AACR-IASLC Joint Conference

Majority of doctors appear to ignore FDA warning to screen high-risk medications

Majority of doctors appear to ignore FDA warning to screen high-risk medications

New clinical study: CeNeRx BioPharma's CXB722 has potential as novel anxiolytic

New clinical study: CeNeRx BioPharma's CXB722 has potential as novel anxiolytic

BARDA invites Aeolus Pharmaceuticals to submit proposal for development of AEOL 10150

BARDA invites Aeolus Pharmaceuticals to submit proposal for development of AEOL 10150

Spectrum Pharmaceuticals achieves its enrollment target in second of two apaziquone Phase 3 trials

Spectrum Pharmaceuticals achieves its enrollment target in second of two apaziquone Phase 3 trials

Bevacizumab drug shows promise to slow tumor growth in lung cancer patients

Bevacizumab drug shows promise to slow tumor growth in lung cancer patients

NOVAVAX completes pre-clinical safety and efficacy study of its RSV vaccine candidate

NOVAVAX completes pre-clinical safety and efficacy study of its RSV vaccine candidate

Patient enrollment in Spherix's global Phase 3 clinical trial NEET completed

Patient enrollment in Spherix's global Phase 3 clinical trial NEET completed

Vion Pharmaceuticals files SPA for Onrigin-LDAC combination Phase II/III trial

Vion Pharmaceuticals files SPA for Onrigin-LDAC combination Phase II/III trial

Preliminary results from Nektar Therapeutics' NKTR-102 Phase 2 study in platinum-resistant ovarian cancer

Preliminary results from Nektar Therapeutics' NKTR-102 Phase 2 study in platinum-resistant ovarian cancer

VaxInnate grants license to Biological E. to develop and commercialize recombinant H1N1 vaccine in India

VaxInnate grants license to Biological E. to develop and commercialize recombinant H1N1 vaccine in India

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.